Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Biorxiv : the Preprint Server for Biology|May 22, 2025
Drug screen reveals new potent host-targeted antivirals against Mpox virusArjit Vijey Jeyachandran, Anne K Zaiss, Nikhil Chakravarty, et al.
Cell Stem Cell|December 1, 2020
Direct Exposure to SARS-CoV-2 and Cigarette Smoke Increases Infection Severity and Alters the Stem Cell-Derived Airway Repair ResponseArunima Purkayastha, Chandani Sen, Gustavo Garcia, et al.
Molecular Neurobiology|January 20, 2018
Combination Therapy with Sulfasalazine and Valproic Acid Promotes Human Glioblastoma Cell Death Through Imbalance of the Intracellular Oxidative ResponseCarlos Gustavo Garcia, Suzana Assad Kahn, Luiz Henrique Medeiros Geraldo, et al.
Plos Pathogens|August 26, 2025
Differential tropisms of old and new world hantaviruses influence virulence and developing host-directed antiviral candidatesArjit Vijey Jeyachandran, Joseph Ignatius Irudayam, Swati Dubey, et al.
Viruses|November 27, 2021
A CRISPR Activation Screen Identifies an Atypical Rho GTPase That Enhances Zika Viral EntryAnh Phuong Luu, Zhenlan Yao, Sangeetha Ramachandran, et al.
The Journal of Infectious Diseases|September 9, 2022
Longitudinal Evaluation of Antibody Persistence in Mother-Infant Dyads After Severe Acute Respiratory Syndrome Coronavirus 2 Infection in PregnancyMary C Cambou, Christine M Liu, Thalia Mok, et al.
Plos One|August 1, 2025
The YoungFitT project: Study protocol for a randomized mixed-methods trial of physical exercise and mind-body interventions, with or without virtual reality, in university studentsSamira Rostami, Adrià Bermudo-Gallaguet, Neus Camins-Vila, et al.
JCI Insight|December 7, 2020
Metabolic reprogramming and epigenetic changes of vital organs in SARS-CoV-2-induced systemic toxicityShen Li, Feiyang Ma, Tomohiro Yokota, et al.
Respiratory Research|January 17, 2025
Optimization of a micro-scale air-liquid-interface model of human proximal airway epithelium for moderate throughput drug screening for SARS-CoV-2Chandani Sen, Tammy M Rickabaugh, Arjit Vijey Jeyachandran, et al.
Cell Reports|March 30, 2021
Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replicationGustavo Garcia, Arun Sharma, Arunachalam Ramaiah, et al.
Pageof 10